Nationwide recall on October 1, 2019, (on the retail stage for over-the-counter merchandise and on the client stage for prescription merchandise) of all of its ranitidine drugs offered in US as a consequence of confirmed contamination with N-Nitrosodimethylamine (NDMA) above ranges established by the FDA
Source link
Related Posts
Add A Comment